SCHEMBL13320653

SCHEMBL13320653

C#Cc1ncn([C@@H]2O[C@H](CO)[C@H](O)C2O)n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.59
▸ SMN1; SMN2 Q16637 2/20 0.59
▸ PNP P00491 2/20 0.59
▸ ADORA1 P30542 2/20 0.59
▸ ALDH1A1 P00352 2/20 0.59
▸ THPO P40225 2/20 0.59
▸ PMP22 Q01453 2/20 0.59
▸ GLA P06280 1/20 0.59
▸ EIF4E P06730 1/20 0.59
▸ CYP3A4 P08684 1/20 0.59
▸ TOP1 P11387 1/20 0.59
▸ TSHR P16473 1/20 0.59
▸ ADORA3 P0DMS8 1/20 0.47
▸ ADORA2A P29274 1/20 0.47
▸ ADK P55263 1/20 0.45
▸ DOT1L Q8TEK3 1/20 0.45
▸ GMNN O75496 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ DNMT1 P26358 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13351996 1.00 LMNA (0.59) LMNASMN1; SMN2PNPADORA1ALDH1A1
SCHEMBL13320568 1.00 LMNA (0.59) LMNASMN1; SMN2PNPADORA1ALDH1A1
SCHEMBL2841617 1.00 LMNA (0.59) LMNASMN1; SMN2PNPADORA1ALDH1A1
SCHEMBL13352081 0.86 LMNA (0.59) LMNASMN1; SMN2PNPADORA1ALDH1A1
SCHEMBL9780439 0.86 LMNA (0.59) LMNASMN1; SMN2PNPADORA1ALDH1A1
SCHEMBL13320587 0.86 LMNA (0.59) LMNASMN1; SMN2PNPADORA1ALDH1A1
SCHEMBL13320530 0.84 LMNA (0.56) LMNASMN1; SMN2PNPADORA1ALDH1A1
SCHEMBL14160485 0.84 LMNA (0.56) LMNASMN1; SMN2PNPADORA1ALDH1A1
SCHEMBL13320552 0.80 LMNA (0.52) LMNASMN1; SMN2PNPADORA1ALDH1A1
SCHEMBL13320536 0.78 LMNA (0.67) LMNASMN1; SMN2PNPADORA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100129317-A1 AZOLE NUCLEOSIDES AND USE AS INHIBITORS OF RNA AND DNA VIRAL POLYMERASES SOUTHERN RESEARCH INSTITUTE (US) 2010-05-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100129317-A1 AZOLE NUCLEOSIDES AND USE AS INHIBITORS OF RNA AND DNA VIRAL POLYMERASES RNASEH1, RNASEL, POLR2E LMNA 739/4885SMN1; SMN2 3616/4885PNP 50/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback